Vic Raso
- Hepatology top 5%
- Biotechnology top 5%
- Transgenic Plants and Applications 8
- Microbial Inactivation Methods 4
- Immunology top 10%
- Toxin Mechanisms and Immunotoxins 13
-
- Monoclonal and Polyclonal Antibodies Research 6
- Radiopharmaceutical Chemistry and Applications 2
- Medical Imaging Techniques and Applications 2
- Oncology top 10%
- Cancer Treatment and Pharmacology 2
-
- DNA and Nucleic Acid Chemistry 3
- Co-authors
- Thomas W. GriffinB. David StollarA. RosowskySteven E. ComeMichael GlodéGlenn SteeleDavid C. LevinWilliam D. Ensminger
- Cited by
- HepatologyBiotechnologyImmunology
- Journals
- Biochemistry (3 papers)Journal of Biological Chemistry (2 papers)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Vic Raso
26 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Hepatology 256
- Biotechnology 159
- Immunology 332
- Radiology, Nuclear Medicine and Imaging 296
- Oncology 350
Countries citing papers authored by Vic Raso
This map shows the geographic impact of Vic Raso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vic Raso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vic Raso more than expected).
Fields of papers citing papers by Vic Raso
This network shows the impact of papers produced by Vic Raso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vic Raso. The network helps show where Vic Raso may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vic Raso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 46 | |
| 2 | 1997 | 5 | |
| 3 | 1997 | 2 | |
| 4 | 1996 | 10 | |
| 5 | Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins. | 1991 | 27 |
| 6 | 1990 | 154 | |
| 7 | 1989 | 11 | |
| 8 | 1988 | 3 | |
| 9 | 1988 | 10 | |
| 10 | 1987 | 11 | |
| 11 | 1982 | 49 | |
| 12 | 1982 | 1 | |
| 13 | Hybrid antibodies with dual specificity for the delivery of ricin to immunoglobulin-bearing target cells. | 1981 | 69 |
| 14 | Pharmacokinetics of the protein antitumor antibiotic neocarzinostatin after bolus injection in humans. | 1979 | 7 |
| 15 | Radioimmunoassay for the detection and quantitation of 5-fluorodexoyuridine. | 1978 | 11 |
| 16 | 1978 | 2 | |
| 17 | 1975 | 41 | |
| 18 | 1975 | 37 | |
| 19 | 1974 | 28 | |
| 20 | 1973 | 11 |
About Vic Raso
Vic Raso is a scholar working on Biotechnology, Immunology, Radiology, Nuclear Medicine and Imaging, Toxicology and Biochemistry, having authored 26 papers that have together received 1.2k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (13 papers), Transgenic Plants and Applications (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Microbial Inactivation Methods (4 papers), DNA and Nucleic Acid Chemistry (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Medical Imaging Techniques and Applications (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Hepatology (256 citations), Biotechnology (159 citations), Immunology (332 citations), Radiology, Nuclear Medicine and Imaging (296 citations) and Oncology (350 citations). Vic Raso has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Thomas W. Griffin, B. David Stollar, A. Rosowsky, Steven E. Come, Michael Glodé, Glenn Steele, David C. Levin, William D. Ensminger, Emil Frei and Lawrence D. Recht. Their work appears in journals such as Biochemistry, Journal of Biological Chemistry, JNCI Journal of the National Cancer Institute, Journal of the American Chemical Society and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.